Union Minister Jitendra Singh inaugurates 'National Biobank' and India's own Longitudinal population data study at CSIR-IGIB
National Biobank
" at the CSIR-Institute of Genomics and Integrative Biology (IGIB) in the national capital today.
The newly launched facility marks a significant stride towards building India's own longitudinal health database and enabling personalised treatment regimens in future, said the Ministry of Science and Technology.
The Biobank will serve as the backbone of a nationwide cohort study, collecting comprehensive genomic, lifestyle, and clinical data from 10,000 individuals across India.
Drawing inspiration from the UK Biobank model, the Indian version is tailored to capture the country's unique diversity across geography, ethnicity, and socio-economic backgrounds. Researchers believe the initiative will aid early diagnosis, improve therapeutic targeting, and bolster the fight against complex diseases such as diabetes, cancer, cardiovascular ailments, and rare genetic disorders, the Ministry added.
"Today, we hold the promise of a future where every Indian may receive individualised treatment tailored to their genetic makeup, lifestyle, and environment," Dr. Jitendra Singh said while addressing the scientists and researchers at IGIB. "This transition to
personalised healthcare
is no longer theoretical--it is becoming reality, driven by indigenous innovations."
Reflecting on the unique health challenges faced by Indians, Dr. Jitendra Singh noted the high prevalence of central obesity, a risk factor often underestimated. He highlighted past research showing that seemingly lean Indians may carry disproportionate fat around their waist, underlining the need for population-specific health strategies. "Our conditions are complex and deeply heterogeneous. This is where the Biobank becomes vital--it allows us to decode that complexity," he said.
The Minister emphasised that India's scientific landscape is evolving rapidly, citing recent advances in quantum technology, CRISPR-based genome editing, and the fight against antimicrobial resistance (AMR). "India is no longer lagging behind--we are among the early adopters, sometimes even ahead," he said. The Biobank, he added, will complement these efforts by generating the kind of high-resolution data that can power AI-driven diagnostics and gene-guided therapies.
Dr. Jitendra Singh also called for deeper collaboration between research institutions, government departments like the Department of Biotechnology, and industry partners, particularly in areas such as AMR and drug development. "Research must extend beyond the lab--it must find takers in the market and beneficiaries in society," he noted.
The
Phenome India Project
, under which the Biobank has been launched, is designed to be a long-term, data-rich study tracking the health trajectories of individuals over several years. It will help scientists uncover disease patterns, gene-environment interactions, and response to therapies--all within the Indian context.
Dr. N. Kalaiselvi, Director General of CSIR and Secretary, DSIR, commended the launch of the Biobank as a bold step toward India's self-reliance in healthcare data. Describing the initiative as a "baby step" with the potential to evolve into a global benchmark, she noted that the diversity and depth of the Indian cohort data could one day rival or even surpass global counterparts like the UK Biobank. Dr. Kalaiselvi highlighted CSIR's holistic efforts in areas like sickle cell anaemia through indigenous CRISPR-based therapies, affordable diagnostics, and collaborative interventions with tribal communities, while urging IGIB scientists to continue setting national examples in data-driven, people-centric research.
Speaking at the occasion, Dr. Souvik Maiti, Director of
CSIR-IGIB
, reflected on the institute's pioneering role in genomics over the past two decades. "We were the first institute in India to begin decoding the human genome at a time when sequencing tools were practically non-existent," he said. Highlighting achievements such as the development of over 300 genetic diagnostics for rare disorders, extensive work on COVID-19 genome sequencing, and the launch of India's first drug genome project, he emphasised IGIB's mission of using global technologies to solve local health challenges.
Dr. Maiti also pointed to ongoing work on women-centric studies, breast cancer genomics, and the development of indigenous CRISPR-based therapies for sickle cell disease, adding that IGIB's research now extends to domains like space biology and AI-based pilot fitness assessments in collaboration with the Indian Air Force. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
12 minutes ago
- Time of India
Head and neck cancer: How your voice, smile, and breath could be under siege
Head and neck cancer is a general term that refers to a wide range of malignant growths that occur in or around the throat, larynx (voice box), nose, sinuses, mouth, and salivary glands. They usually arise in the squamous cells of the lining that covers the moist, mucosal surfaces within the head and neck region. Collectively, head and neck cancers account for approximately 4% of all Indian and worldwide cancers. If they are caught early, most head and neck cancers are very curable, but because of the intricate anatomy and late detection in most cases, treatment can be difficult and may affect important functions like speaking, breathing, and swallowing. Common head and neck cancers * Oral cavity cancer: Involves the lips, front two-thirds of the tongue, gums, inner cheeks, floor of the mouth, and the hard palate. * Pharyngeal cancer: Occurs in the throat (pharynx), including the nasopharynx (at the back of the nose), oropharynx (mid-part of the throat, including tonsils and base of tongue), and hypopharynx (lower part of the throat). * Laryngeal cancer: Develops in the voice box. * Nasal cavity and paranasal sinus cancer: Occurs in the cavities behind the nose. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Providers are furious: Internet access without a subscription! Techno Mag Learn More Undo * Salivary gland cancer: Although less common, may arise in glands that make saliva. Common risk factors associated with head and neck cancer There are several environmental, lifestyle, and biological conditions that contribute to head and neck cancer. They are: 1. Tobacco use One of the strongest risk factors, tobacco—whether in smoked or smokeless forms—is responsible for most head and neck cancers. Chronic irritation and DNA damage results from long-term exposure to tobacco carcinogens within the cells lining the mouth, throat, and larynx, substantially increasing cancer risk. 2. Alcohol consumption Heavy and chronic alcohol consumption, particularly when supplemented with tobacco smoking, raises the risk exponentially. Alcohol serves as a solvent that facilitates carcinogens in tobacco to enter tissue more readily. Synergistic action of tobacco and alcohol is especially potent in oropharyngeal and oral cavity cancers. 3. Human Papillomavirus (HPV) infection HPV, especially the high-risk type 16, is a leading cause of oropharyngeal cancers, notably in the tonsils and tongue base. As opposed to tobacco-caused cancers, HPV-related head and neck cancers tend to occur among younger persons and non-smokers and could have a more favorable prognosis. 4. Poor dental health and oral hygiene Poor dental hygiene, chronic denture irritation due to ill-fitting dentures, and gum disease can predispose to oral cancers. Inadequate dental care can postpone early detection of suspicious lesions. 5. Diet and nutrition deficiency A diet poor in vegetables and fruits—high in antioxidants and nutrients—can enhance susceptibility to oral cavity and pharyngeal cancers. Inadequate consumption of vitamin A and iron has been most commonly linked with mucosal degeneration and carcinogenesis. 6. Occupational exposure Exposure to some industrial chemicals like asbestos, wood dust, formaldehyde, and nickel compounds has been associated with cancers of the sinuses, nasal cavity, and larynx. Construction, chemical, textile, and leather workers are possibly at risk. 7. Radiation exposure Prior radiation therapy to the head and neck region, usually for benign disease in childhood or another cancer, will raise the long-term risk of thyroid and salivary gland cancers. 8. Epstein-Barr Virus (EBV) Infection EBV is strongly linked with nasopharyngeal carcinoma, especially in Southeast Asian populations. Nasopharyngeal cancer occurs more frequently in areas such as northeastern India, southern China, and North Africa. 9. Age and gender The risk of head and neck cancer increases with age, typically affecting individuals over 40. Men are two to three times more likely than women to develop these cancers, primarily due to higher rates of tobacco and alcohol use. 10. Genetic predisposition Although less common, certain inherited genetic syndromes such as Fanconi anemia and dyskeratosis congenita can predispose individuals to head and neck cancers at a young age. Head and neck cancers are eminently preventable through life-style modifications, earlier screening, and immunization (in the case of HPV). Public awareness regarding risk factors—specifically tobacco and alcohol abstinence, safe sex, and frequent dental check-ups—is the cornerstone of prevention of incidence and enhancing outcomes. Dr Harish Verma, Associate Director - Surgical Oncology at CK Birla Hospital, Gurugram
Indian Express
4 hours ago
- Indian Express
Delhi Confidential: Beyond the blue
At a recent event, when someone asked Union Science Minister Jitendra Singh the all-important question — when will the first Indian astronaut blast off aboard the Gaganyaan Mission — he said India is working not just on sending someone up into space but also deep into the sea. Enter the Samudrayaan Mission, which aims to take Indians 6,000 metres below the ocean's surface to explore the deep blue frontier. When asked about the delay in launching either of the two ventures, the minister said the real goal is not just to send someone up or down, it's also to make sure they return safely to Earth. Cool & Comfortable Union Agriculture Minister Shivraj Singh Chouhan on Monday asked the officials of Indian Council of Agricultural Research (ICAR) not to operate air conditioners below 24 degrees minister's advice came during the 96th annual general meeting of the ICAR. Chouhan was sharing the dais with MoS, Agriculture and Farmers Welfare, Bhagirath Chaudhary, MoS, Animal Husbandry, S P Singh Baghel and MoS (independent charge), Science and Technology, Jitendra Singh. It is learnt that soon after the meeting started, some of the ministers complained of the AC being too cold for comfort, prompting Chouhan to instruct the officials not to run the AC system below 24 degrees in future.
Time of India
5 hours ago
- Time of India
Shubhanshu Shukla has a phone call with the ISRO chief while in outer space, updates him on Axiom-4's scientific experiments
Shubhanshu Shukla, the second Indian astronaut to go on a mission to outer space as part of Axiom-4, gave an update to the Indian Space Research Organization (ISRO) chairman V Narayanan on Sunday, July 6. In a phone call with the ISRO chief, which was first reported on by the Press Trust of India (PTI), Shubhanshu expressed his gratitude for the efforts of ISRO in ensuring Axiom-4's success, while also updating him on the particulars of how the mission was progressing. Shubhanshu Shukla's work with Axiom-4 includes scientific studies on bone health and radiation exposure. During the call, ISRO chairman Narayanan expressed his eagerness to discuss the Axiom-4 mission after Shubhanshu's return to Earth, as it would help with developing India's own Ganganyaan program. Shubhanshu Shukla's Axiom-4 mission is conducting experiments Private Astronaut Missions are redefining access to space for the larger global community. We are at the forefront of the commercial space revolution, presenting unparalleled opportunities for countries like India to #ExperienceSpace. #Ax4 — Axiom Space (@Axiom_Space) June 28, 2025 Axiom-4 is taking advantage of its time in outer space to conduct missions studying bone health and radiation exposure. The bone health studies involve analyzing how bones change their behavior under microgravity conditions. This analysis could go on to further research into combating osteoporosis, among other bone diseases. The radiation exposure studies, on the other hand, are geared towards improving the safety conditions at the International Space Station (ISS), allowing for longer-term space missions to be safely planned out and executed. Aside from Shubhanshu, the Axiom-4 mission crew also includes Poland's Sławosz Uznański-Wiśniewski, Hungary's Tibor Kapu, and the United States's Peggy Whitson. To Peggy, Shux, Sławosz, and Tibor, here are some loving words to commemorate this historic moment. #Ax4 — Axiom Space (@Axiom_Space) June 25, 2025 Shubhanshu's own callsign is 'Shux', which is reflected in some of the updates given by Axiom Space about the mission's experiments, such as one about micro-algae, which said: "Shux deployed samples for the Space Micro Algae investigation. These tiny organisms might one day help sustain life in space, providing food, fuel, and even breathable air. But first, we need to understand how they grow and adapt in microgravity." ISRO plans to leverage Axiom-4 findings for the Ganganyaan program First Indian Gaganyatri Shubhanshu Shukla was received in the International Space Station on June 26, 2025. Today is the historical day when he had interaction with Hon'ble PM of India Shri Narendra Modi Ji. This interaction of Prime Minister inspires and motivates 140 crore… — ISRO (@isro) June 28, 2025 Upon Shubhanshu Shukla's return to the Earth, ISRO will leverage his experiences on the Axiom-4 mission to further India's Ganganyaan program. This program is intended to demonstrate India's own capacity to launch manned spaceflight missions into low orbit above the Earth, so it will have a lot to learn from Axiom Space's missions.
